Institutional review of the implementation and use of a Clostridium difficile infection bundle and probiotics in adult trauma patients

被引:2
作者
Bommiasamy, Aravind K. [1 ]
Connelly, Christopher [1 ]
Moren, Alexi [1 ]
Dodgion, Chris [1 ]
Bestall, Kelsey [1 ]
Cline, Anthony [1 ]
Martindale, Robert G. [1 ]
Schreiber, Martin A. [1 ]
Kiraly, Laszlo N. [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Surg, 3181 SW Sam Jackson Pk Rd,Mail Code L223, Portland, OR 97239 USA
关键词
Trauma; Probiotic; Clostridium difficile; Infection; ANTIBIOTIC-ASSOCIATED DIARRHEA; PREVENTION; MULTICENTER; EPIDEMIOLOGY; THERMOMETERS; MORTALITY; STRAIN; SPREAD;
D O I
10.1016/j.amjsurg.2018.01.005
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Clostridium difficile infection (CDI) is a common cause of healthcare associated infections contributing to morbidity and mortality. Our objective was to evaluate the impact of the implementation of a CDI bundle along with probiotic utilization. Methods: A retrospective review of trauma admissions from 2008 to 2014 was performed. The CDI bundle was implemented in stages from 2009 through 2014 with probiotics initiated in 2010. The bundle included changes in cleaning practices, education, screening, and contact precautions. Results: 4632 (49%) patients received antibiotics with 21% receiving probiotics. Probiotic use was associated with increased age, male sex, more severely injured, and antibiotic use. CDI incidence decreased from 11.2 to 4.8 per 1000 admissions, p = .03. Among patients who received antibiotics CDI incidence decreased from 2.2% to 0.7%, p = .01. Conclusions: We report the largest series of a CDI bundle implementation including probiotics. During the period of adoption of these interventions, the incidence of CDI decreased significantly. (c) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:825 / 830
页数:6
相关论文
共 39 条
  • [1] Proposed Checklist of Hospital Interventions to Decrease the Incidence of Healthcare-Associated Clostridium difficile Infection
    Abbett, Sarah K.
    Yokoe, Deborah S.
    Lipsitz, Stuart R.
    Bader, Angela M.
    Berry, William R.
    Tamplin, Elise M.
    Gawande, Atul A.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (11) : 1062 - 1069
  • [2] Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial
    Allen, Stephen J.
    Wareham, Kathie
    Wang, Duolao
    Bradley, Caroline
    Hutchings, Hayley
    Harris, Wyn
    Dhar, Anjan
    Brown, Helga
    Foden, Alwyn
    Gravenor, Michael B.
    Mack, Dietrich
    [J]. LANCET, 2013, 382 (9900) : 1249 - 1257
  • [3] Anderson DJ, 2017, LANCET, V389, P805, DOI [10.1016/S0140-6736(16)31588-4, 10.1016/s0140-6736(16)31588-4]
  • [4] Evaluation of the Cepheid Xpert Clostridium difficile Epi Assay for Diagnosis of Clostridium difficile Infection and Typing of the NAP1 Strain at a Cancer Hospital
    Babady, N. Esther
    Stiles, Jeffrey
    Ruggiero, Phyllis
    Khosa, Perminder
    Huang, David
    Shuptar, Susan
    Kamboj, Mini
    Kiehn, Timothy E.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (12) : 4519 - 4524
  • [5] Infection prevention and control of Clostridium difficile: a global review of guidelines, strategies, and recommendations
    Balsells, Evelyn
    Filipescu, Teodora
    Kyaw, Moe H.
    Wiuff, Camilla
    Campbell, Harry
    Nair, Harish
    [J]. JOURNAL OF GLOBAL HEALTH, 2016, 6 (02)
  • [6] Bron PA, 2017, BR J NUTR, V19, P1
  • [7] BROOKS SE, 1992, INFECT CONT HOSP EP, V13, P98
  • [8] Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa
    Castagliuolo, I
    Riegler, MF
    Valenick, L
    LaMont, JT
    Pothoulakis, C
    [J]. INFECTION AND IMMUNITY, 1999, 67 (01) : 302 - 307
  • [9] Rethinking Strategies to Select Antibiotic Therapy in Clostridium difficile infection
    Chopra, Teena
    Goldstein, Ellie J. C.
    Gorbach, Sherwood L.
    [J]. PHARMACOTHERAPY, 2016, 36 (12): : 1281 - 1289
  • [10] Inhibitory activity spectrum of reuterin produced by Lactobacillus reuteri against intestinal bacteria
    Cleusix, Valentine
    Lacroix, Christophe
    Vollenweider, Sabine
    Duboux, Marc
    Le Blay, Gwenaelle
    [J]. BMC MICROBIOLOGY, 2007, 7 (1)